4//SEC Filing
Samuels Camille D 4
Accession 0000899243-20-017398
CIK 0001463361other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 5:30 PM ET
Size
6.6 KB
Accession
0000899243-20-017398
Insider Transaction Report
Form 4
Samuels Camille D
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-18+25,000→ 25,000 totalExercise: $9.14Exp: 2030-06-17→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the one-year anniversary measured from June 18, 2020 or (ii) the date of the 2021 Annual Meeting of the Issuer's stockholders, assuming continuous service as a Director until such vesting date.
- [F2]The reporting person is a member of VR Management, LLC (the "Management Company"). Under an agreement between the reporting person and the Management Company, the reporting person is deemed to hold the reported option and the shares underlying the option for the sole benefit of the Management Company and must exercise the reported option solely upon the direction of the Management Company, which is entitled to the shares underlying the option. The Management Company may be deemed the indirect beneficial owner of the shares underlying the option, and the reporting person may be deemed the indirect beneficial owner of the reported shares underlying the option through her interest in the Management Company. The reporting person disclaims beneficial ownership of the reported shares except to the extent of her pecuniary interest therein.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001354034
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 5:30 PM ET
- Size
- 6.6 KB